Hoshi Iryo-Sanki (7634) Q4 2026 earnings summary

Executive summary

• Revenue increased 2.8% year-over-year to ¥15,520 million, while operating profit declined 3.2% and net profit attributable to shareholders fell 6.2%.

• The company prioritized stable supply of products and services, safety, and social responsibility in the medical, nursing, and welfare sectors.

Financial highlights

• Operating profit: ¥1,919 million (down 3.2% year-over-year).

• Ordinary profit: ¥2,000 million (down 2.5% year-over-year).

• Net profit attributable to shareholders: ¥1,372 million (down 6.2% year-over-year).

• Comprehensive income: ¥1,845 million (up 19.6% year-over-year).

• Cash and equivalents at year-end: ¥5,910 million.

Outlook and guidance

• Next fiscal year guidance: revenue ¥15,660 million (+0.9%), operating profit ¥1,980 million (+3.2%), ordinary profit ¥2,060 million (+3.0%), net profit attributable to shareholders ¥1,400 million (+2.0%).

• Focus on leveraging core business strengths, expanding through M&A, and enhancing operational efficiency via DX and process review.